US Patent 7514537 Chimeric immunoreceptor useful in treating human gliomas

US Patent 12128069 Treatment of cancer using chimeric antigen receptor and protein kinase a blocker

US Patent 12065492 Anti-B7-H6 antibody, fusion proteins, and methods of using the same

US Patent 11999802 Compositions and methods for selective protein degradation

US Patent 11999794 Human mesothelin chimeric antigen receptors and uses thereof

US Patent 11993652 Tagged chimeric effector molecules and receptors thereof

US Patent 11981731 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

US Patent 11975026 CD19 and CD22 chimeric antigen receptors and uses thereof

US Patent 11952428 BCMA chimeric antigen receptors and uses thereof

US Patent 11939389 BCMA chimeric antigen receptors and uses thereof

US Patent 11919946 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

US Patent RE49847 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain

US Patent 11872249 Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain

US Patent 11872248 Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing

US Patent 11865167 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

US Patent 11858976 Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereof

US Patent 11851659 Compositions and methods for immunooncology

US Patent 11850262 Compositions and methods for CAR T cell therapy

US Patent 11834676 T cell receptor-deficient T cell compositions

US Patent 11834511 Compositions and methods for CD20 immunotherapy

US Patent 11779602 Methods of use for CAR T cells